As depicted in Figure 9, OC exerts its anti-inflammatory and tumor-suppressive effects primarily through the downregulation of PAR-2 expression, thereby disrupting key oncogenic and inflammatory signaling cascades integral to CRC progression. This evidence concerns the gene F2RL1 and colorectal carcinoma.